
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES123
A Cochrane review237 found a significant increase in the risk of hyperkalaemia with A2RB
compared to placebo/no treatment (two studies, 194 patients); RR 4.93, 95% CI 1.87 to 15.65.
A2RB were not found to be associated with an increased risk of cough compared to placebo/no
treatment. Level 1++

[@Remuzzi_2004]

